CELYAD ONCOLOGY Stock Bullish Momentum With A 10% Jump So Far On Tuesday
Celyad Oncology’s (CYAD.BR) stocks experienced an unexpected surge on the BEL 20 market index on Tuesday. The company saw a ten percent increase in their stock’s value, climbing up to EUR0.57. This substantial rise starkly contrasted the overall market trend which followed a downward trajectory, with the market index falling by 0.3% to EUR3,704.94. Hence,…
